Catheter Stabilization Devices Market (2026 - 2033) Size, Share, & Trends Analysis Report By Product (Arterial Securement Devices, CVC Securement Devices, Peripheral Securement Devices), By End Use (Hospitals, Home Healthcare Providers), By Region, And Segment Forecasts

Catheter Stabilization Devices Market Summary

The global catheter stabilization devices market size was estimated at USD 1.84 billion in 2025 and is projected to reach USD 2.77 billion by 2033, growing at a CAGR of 5.14% from 2026 to 2033. Factors such as increasing demand for minimally invasive surgeries; high prevalence of lifestyle diseases, such as cardiovascular diseases, renal failure, & cancer; increase in the number of surgeries that may require these devices for postoperative care; and an increase in the need to reduce catheter-associated complications & infections are expected to drive the market. Aging also increases the need for these devices.

The rising prevalence of chronic diseases is one of the most significant factors driving the growth of the catheter stabilization devices market. Conditions such as cardiovascular disorders, cancer, diabetes, and kidney disease often require frequent or long-term use of catheters for therapies such as chemotherapy, hemodialysis, parenteral nutrition, and intravenous drug delivery. As the global burden of these chronic illnesses continues to increase, fueled by aging populations, lifestyle changes, and higher life expectancy, the demand for secure and reliable catheter placement has grown considerably. Catheter stabilization devices are critical in reducing the risks of complications such as accidental dislodgement, leakage, and catheter-associated bloodstream infections, which are common challenges in long-term catheter use. Therefore, Healthcare providers prioritize advanced securement solutions to improve patient safety, enhance treatment efficiency, and reduce hospital readmissions related to catheter failures or infections. This increasing reliance on catheters in managing chronic conditions directly translates into sustained market growth for stabilization devices, making them an essential component of modern chronic disease management strategies.

According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, around 11.1% of adults aged 20-79 equivalent to 1 in 9 people are currently living with diabetes, with more than 40% unaware of their condition. Looking ahead, projections indicate that by 2050, 1 in 8 adults, or approximately 853 million people, is expected to be living with diabetes, representing a 46% increase from current levels.

As per data published by WHO in December 2024

Noncommunicable diseases (NCDs) caused at least 43 million deaths in 2021, accounting for 75% of all non-pandemic-related deaths worldwide.

• In 2021, 18 million people died from an NCD before age 70, with 82% of these premature deaths occurring in low- and middle-income countries.

• 73% of all NCD deaths were reported in LMICs.

• Cardiovascular diseases were the leading cause, responsible for 19 million deaths, followed by:

• Cancers: 10 million deaths

• Chronic respiratory diseases: 4 million deaths

• Diabetes (including kidney disease from diabetes): over 2 million deaths

Key Cardiovascular Disease (CVD) Statistics in Australia,2025

Source: AIHW, 2025

The rising incidence of chronic kidney disease and related renal disorders has increased demand for catheter stabilization devices. Frequent dialysis and long-term catheter use require securement solutions to prevent complications, improve treatment outcomes, and drive market growth. For instance, in 2025, according to the Institute for Health Metrics and Evaluation, in 2023, the number of global cases of kidney failure requiring replacement therapy was estimated at 4.59 million across both sexes and all age groups, with an age-standardised prevalence of 50.7 (46.1-56.0) per 100,000 population. Over the previous three decades, its prevalence had shown a consistent upward trend worldwide.

The number of patients requiring secure, stable vascular access has increased. This has created a stronger demand for effective stabilization solutions that can reduce the risk of catheter movement, infections, and related complications.

Technological advancements are a key driver of the catheter stabilization devices market, significantly enhancing product performance, patient safety, and clinical outcomes. Innovations in adhesive technologies have led to the development of skin-friendly, hypoallergenic materials that provide strong fixation while minimizing irritation and discomfort, making them suitable for long-term use. In addition, the introduction of sutureless securement systems has reduced the risk of needlestick injuries and catheter-related infections, improving overall patient safety and reducing healthcare costs. The shift toward sutureless securement devices is another major technological leap, minimizing the risk of needlestick injuries and improving workflow efficiency for healthcare professionals. For instance, BD offers the BD StatLock Catheter Stabilization Device, a widely used solution that secures catheters without sutures, reducing complications such as dislodgement and infection.

Market Concentration & Characteristics

The catheter stabilization devices market is growing as healthcare providers focus on patient safety and infection prevention across settings. The rising use of catheters in hospitals, along with the growing demand in home care and outpatient settings, is driving market expansion. Continuous product improvements, including better adhesives, skin-friendly materials, and suture-free designs, enhance device performance and patient comfort. These advancements are encouraging wider adoption among healthcare providers. In addition, companies are actively pursuing partnerships, product launches, and regional expansion strategies, which are strengthening competition and contributing to the global market's overall development and growth.

Innovation has influenced the expansion of the catheter stabilization devices market. Advancements such as improved adhesives, antimicrobial materials, and suture less designs have enhanced patient safety, comfort, and device reliability. These improvements reduce complications such as infections and catheter dislodgement, encouraging healthcare providers to adopt modern solutions over traditional methods. In addition, easy-to-use designs and products developed for long-term and home care settings have widened their applications. As a result, continuous technological progress has played a key role in increasing adoption and driving overall market growth.

In October 2025, Cathetrix, a developer of smart catheter stabilization devices, presented two breakthrough innovations at MEDICA 2025. The company is expected to launch Nephro-Safe, described as the world’s most advanced nephrostomy tube stabilizer, and showcase its flagship product, Foley Safe, the first Foley catheter stabilizer with active protection.

Regulatory frameworks play a crucial role in shaping the catheter stabilization devices market by setting product standards, defining approval processes, and establishing market entry requirements. Authorities such as the U.S. Food and Drug Administration and the European Medicines Agency enforce strict guidelines to ensure device safety and effectiveness. Although compliance can increase costs and extend approval timelines, it enhances product quality and reliability. At the same time, regulations focused on infection control and patient safety have encouraged the adoption of advanced stabilization solutions, supporting innovation and market growth.

July 2025, ASTM F623-25 outlined performance requirements for short-term, single-use Foley catheters, specifying materials, sizes, usage scope, and exclusions while emphasizing regulatory compliance and safety considerations.

Mergers and acquisitions in the catheter stabilization devices market have been increasing as companies seek to strengthen their capabilities and expand their product ranges. Firms are pursuing strategic deals to access new technologies, improve their presence in vascular access solutions, and enter new regions. These activities are also helping organizations enhance competitiveness and operational efficiency. Overall, the rise in such transactions indicates ongoing market consolidation, which supports innovation and contributes to sustained industry growth.

In 2025, Argon Medical, a provider of medical device solutions for interventional procedures, announced that it had acquired selected assets of Accurate Medical Therapeutics Ltd., including the SeQure and DraKon microcatheter product lines, from Guerbet SA, a global leader in medical imaging.

Product Insights

Arterial securement devices segment dominated the catheter stabilization devices industry in 2025, due to the extensive use of arterial catheters in many cardiovascular surgeries and cancer therapies. The widespread use of these devices makes securing them important to reduce complications.

The CVC securement devices segment is expected to grow at the fastest CAGR over the forecast period. CVC security is gaining importance owing to benefits such as the absence of interruptions during treatments, fewer repeat procedures and reinsertions, and lower CVC replacement costs. An effective securement is crucial for critically ill patients requiring long-term therapy, such as in the case of cancer. According to the WHO, in 2022, an estimated 20 million people were newly diagnosed with cancer, and approximately 9.7 million individuals died from cancer-related causes. Approximately 53.5 million people were alive within 5 years of cancer diagnosis. By 2050, the number of new cancer cases is projected to rise to over 35 million, marking a 77% increase from the 2022 estimate.

For instance, in 2025, according to NIH, the U.S was expected to record approximately 2,041,910 new cancer cases and 618,120 deaths related to the disease.

End Use Insights

Hospitals segment led the catheter stabilization devices industry, accounting for the largest revenue share in 2025. A large number of surgeries are performed in hospitals; therefore, catheters are widely used for various treatments. The prevalence of infections associated with their usage is high in hospitalized patients. Catheter-associated Urinary Tract Infections (CAUTI) are the most commonly reported hospital-acquired infections, and their prevalence continues to increase.

In 2025, according to the UK Health Security Agency, based on Hospital Episode Statistics data, there were 189,756 hospital admissions linked to urinary tract infections (UTIs) in England during the 2023-2024 financial year, and analysis by the UK Health Security Agency indicated that cases with UTIs as the main diagnosis led to hospital costs surpassing USD 696.92 million.

As a result, there is a growing need for safer, more secure catheter stabilization devices to reduce the risk of infections.

The home healthcare providers segment is expected to grow significantly over the forecast period. Urinary catheters are also used at home for incontinence, retention, and post-surgical care. In the U.S., 53% of homebound older adults and up to 45% of women, including 7% to 37% of women aged 20 to 39, experience urinary incontinence. This growing prevalence drives the demand for catheter stabilization devices among home healthcare settings, where  secure placement, reduce complication risks, and improved patient comfort are critical to delivering reliable, high-quality care.

Regional Insights

North America dominated the catheter stabilization devices market with the largest revenue share of 36.70% in 2025. This region's large share can be attributed to the high number of surgeries, which drives the demand for stabilization devices. According to a CIHI report, surgical volumes in Canada rose to 2.33 million in 2023-2024, an increase of 5% compared to 2019-2020. The widespread adoption of catheterization techniques for examination, diagnosis, and treatment is also a factor driving market growth. The increasing use of intravascular catheters in this region is expected to further drive the market.

U.S. Catheter Stabilization Devices Market Trends

The U.S. catheter stabilization devices market led North America in 2025, with the largest revenue share. It has a large and growing patient base requiring catheter-based treatments for chronic conditions such as cardiovascular diseases, cancer, and kidney disorders, which significantly increases the demand for effective stabilization devices. The high frequency of hospital admissions and the need for long-term care further support this demand.

In 2025, according to the Heart Failure Epidemiology and Outcomes Statistics, approximately 6.7 million Americans over 20 years of age have heart failure, and the prevalence is expected to rise to 8.7 million in 2033. Heart failure was a contributing cause in 425,147 deaths, accounting for 45% of cardiovascular deaths in the United States in 2022. These patterns reflect the rising burden of chronic conditions and the increasing dependence on catheter-based treatments across the United States. Consequently, the need for advanced catheter stabilization devices is likely to grow, supported by the focus on improving patient safety, minimizing complications, and optimizing treatment outcomes.

Europe Catheter Stabilization Devices Market Trends

The Europe catheter stabilization devices market held a substantial share of the industry in 2025. The growing number of dialysis patients, especially those choosing home hemodialysis, along with the rising prevalence of chronic conditions such as cardiovascular and urinary diseases, drives market demand. In 2024, an estimated 7.2 million people in the UK were affected by Chronic Kidney Disease (CKD) stages 1-5. Of these, approximately 3.25 million were in the more advanced stages (3-5), where symptoms become challenging to manage. This trend highlights the urgent need for effective treatment options and supportive medical devices.

Catheter stabilization devices market in the UK is growing through its well-established healthcare system and strong emphasis on infection control and patient safety. The increasing number of hospital admissions and procedures requiring catheter use is driving demand for securement solutions.

For instance, in 2025, according to the Royal College of Surgeons of England, over 90,000 individuals in the United Kingdom were using long-term indwelling catheters, with around 75% aged 70 or older. In addition, the Chief Medical Officer’s 2023 report indicated that people aged 85 and older are expected to account for 7% of the population by 2066.

Clinical guidelines and healthcare policies are promoting the use of advanced stabilization devices instead of conventional methods. Furthermore, the rising prevalence of chronic conditions and the expansion of home-based care are also supporting market development.

Asia Pacific Catheter Stabilization Devices Market Trends

The Asia Pacific catheter stabilization devices market is expected to grow at the fastest CAGR over the forecast period. The aging population, improving healthcare infrastructure, and rising hospital numbers in China 39,000 units in 2024—drive the market. With the country’s population projected to grow to 1.39 billion by 2035 and 28% of the population expected to be over 60 by 2040, healthcare demand is surging. Increasing government efforts to enhance the healthcare system and manage rising expenditures further support market growth.

Catheter stabilization devices market in Japan dominated the Asia Pacific region in 2025, owing to a large patient pool, a growing target population, high unmet needs, and advanced infrastructure. Growing demand for various surgeries and increasing awareness are expected to boost market growth. Japan has over 8,000 hospitals and clinics, including public and private facilities. The government regulates nearly 60% of these facilities and is key in maintaining quality and accessibility.

India catheter stabilization devices market is growing due to the rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, and kidney conditions, which increase the need for catheter-based treatments. Expanding healthcare infrastructure, rising hospital admissions and surgical procedures, and improved access to medical services are further supporting demand. In 2026, according to AIR, the All India Institute of Medical Sciences (AIIMS), New Delhi, the Department of Surgical Disciplines had performed over 1,000 robotic surgeries in the previous 13 months, highlighting a notable advancement in surgical care across the country. In addition, increasing awareness of infection control and patient safety, along with government initiatives to strengthen healthcare systems, is encouraging the adoption of advanced catheter stabilization solutions across hospitals and home care settings.

Latin America Catheter Stabilization Devices Market Trends

Latin America catheter stabilization devices market growing due to ongoing improvements in healthcare infrastructure and broader access to medical services across countries such as Brazil and Mexico. In 2026, according to NIH, the Brazilian Registry of Pulsed Field Catheter Ablation for treating atrial fibrillation indicated that, in Brazil, the technique delivered strong immediate effectiveness, maintained a favorable safety profile, and was quickly adopted, with experienced centers demonstrating high procedural efficiency and a relatively short learning curve.

The increasing burden of chronic diseases, along with a rising number of surgical and minimally invasive procedures, is driving the need for catheter-based treatments. Expanding hospital networks and investments in healthcare facilities are further supporting demand.

MEA Catheter Stabilization Devices Market Trends

The Middle East and Africa catheter stabilization devices market is expanding as healthcare systems continue to develop and investments in hospitals and medical facilities increase across the region. The growing burden of chronic illnesses, combined with a rising number of surgical and minimally invasive procedures, is increasing the need for catheter-based care. The GSCS 2025, held in December 2025 at Conrad Dubai, highlighted the advancement of healthcare in the Middle East by bringing together global expertise, advanced surgical techniques, and emerging leaders in cardiac care, thereby supporting the region’s progress in specialized medical services and innovation. Improved access to healthcare services in both urban and semi-urban areas is further supporting demand. In addition, heightened focus on infection control and patient safety is encouraging the adoption of advanced catheter stabilization solutions.

Key Catheter Stabilization Devices Company Insights

Some of the major companies in the catheter stabilization devices industry are BD, 3M, and B. Braun Medical Inc. These companies stay competitive globally through continuous innovation, strategic partnerships, and expanding product portfolios. They invest in R&D to improve device safety and comfort, comply with international regulations, and tap into emerging markets. Leading players also focus on mergers and acquisitions to strengthen their market presence and meet the growing demand driven by the aging population and chronic diseases.

Recent Developments

• In January 2026, B. Braun Medical Inc. launched the Clik-FIX Epidural/Peripheral Nerve Block Catheter Securement Device. The low-profile, soft, secure device minimizes catheter displacement and dislodgement during regional anesthesia, enhancing patient safety and pain control. 

• In December 2025, AVACEN, Inc. announced that it had been granted a U.S. utility patent for its CATHeter STAbilization (CATHSTA) device. The device was developed for high-acuity applications requiring secure large-bore vascular access, including transcatheter cardiac procedures, mechanical circulatory support, indwelling use, extracorporeal membrane oxygenation, and renal replacement therapies.

• In October 2025, Cathetrix showcased Foley Safe, an advanced catheter stabilizer with active protection, at MEDICA 2025 in Düsseldorf, Germany, highlighting innovation in catheter safety and improved patient care. 

Catheter Stabilization Devices Market Report Scope

Global Catheter Stabilization Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global catheter stabilization devices market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Arterial Securement Devices

  • CVC Securement Devices

  • Peripheral Securement Devices

  • Urinary Catheters Securement Devices

  • Chest Drainage Tubes Securement Devices

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Home Healthcare Providers

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait